Table 1.
Baseline Characteristics of both subpopulations at the time of ACS presentation.
| Variables | Total (N = 787) | G1 (N = 698) | G2 (N = 89) | P Value |
|---|---|---|---|---|
| Age (years) | 61 (SD ± 11) | 60.2 (SD ± 11) | 67 (SD ± 10) | <0.001 |
| Male Sex | 645 (82 %) | 572 (81.9 %) | 73 (82 %) | 0.986 |
| Hypertension | 496 (63 %) | 441 (63.2 %) | 55 (61.8 %) | 0.799 |
| No DM | 625 (79.4 %) | 563 (80.5 %) | 63 (71 %) | 0.030 |
| NIDDM | 125 (17.5 %) | 108 (15.5 %) | 17 (19 %) | 0.378 |
| IDDM | 37 (4.7 %) | 28 (4 %) | 9 (10 %) | 0.010 |
| History of Smoking | 480 (61 %) | 430 (62 %) | 50 (56 %) | 0.323 |
| Dyslipidemia | 494 (62.7 %) | 442 (63.2 %) | 52 (58.4 %) | 0.368 |
| Hyperuricemia | 19 (2.41 %) | 16 (2.29 %) | 3 (3.7 %) | 0.532 |
| Obesity | 290 (36.9 %) | 267 (38.3 %) | 23 (25.8 %) | 0.022 |
| Family History of Cardiovascular Disease | 137 (17.4 %) | 130 (18.6 %) | 7 (7.9 %) | 0.012 |
| Sedentarism | 441 (56 %) | 405 (58 %) | 36 (40.4 %) | 0.002 |
| Length of Stay (days) | 3 (IQR 2–5) | 3 (IQR 2–6) | 4 (IQR 3–5) | 0.151 |
| Mean LVEF al time of discharge (%) | 54 (SD ± 10.5) | 54 (SD ± 10) | 53 (SD ± 11) | 0.445 |
| Number of Affected vessels | ||||
| 0 | 73 (9.27 %) | 63 (9.02 %) | 10 (11.2 %) | 0.498 |
| 1 | 338 (42.9 %) | 306 (43.8 %) | 32 (35.9 %) | 0.157 |
| 2 | 277 (35.2 %) | 244 (34.9 %) | 33 (37.1 %) | 0.693 |
| 3 | 100 (12.7 %) | 87 (12.5 %) | 13 (14.6 %) | 0.569 |
| Left Main | 20 (2.54 %) | 18 (2.58 %) | 2 (2.25 %) | 0.851 |
| Left Anterior Descending | 475 (60.4 %) | 421 (60.3 %) | 54 (60.7 %) | 0.948 |
| Left Circumflex | 314 (39.9 %) | 276 (39.5 %) | 38 (42.7 %) | 0.567 |
| Right Coronary | 363 (46.1 %) | 315 (45.1 %) | 48 (53.9 %) | 0.117 |
| Number of Treated Lesions | ||||
| 1 | 405 (51.4 %) | 368 (53.5 %) | 37 (41.6 %) | 0.047 |
| 2 | 239 (30.4 %) | 209 (30.3 %) | 30 (33.7 %) | 0.467 |
| 3 | 70 (8.89 %) | 59 (8.6 %) | 11 (12.3 %) | 0.224 |
G1 = Non-Oncologic Group, G2 = Oncologic Group, DM = Diabetes Mellitus, NIDDM= Non-Insulin Dependent Diabetes Mellitus, IDDM= Insulin-Dependent Diabetes Mellitus.